Compile Data Set for Download or QSAR
Report error Found 1344 Enz. Inhib. hit(s) with all data for entry = 11476
TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619040(US20230295119, Compound 8A)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619042(US20230295119, Compound 8C)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619043(US20230295119, Compound 8D)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619045(US20230295119, Compound 8F)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619046(US20230295119, Compound 8G)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619047(US20230295119, Compound 8H)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619049(US20230295119, Compound 8J)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619050(US20230295119, Compound 8K)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619052(US20230295119, Compound 8M)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619053(US20230295119, Compound 8N)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619054(US20230295119, Compound 8O)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619055(US20230295119, Compound 9W | US20230295119, Compou...)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619056(US20230295119, Compound 9B)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619057(US20230295119, Compound 9C)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619059(US20230295119, Compound 9E)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619061(US20230295119, Compound 9G)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619062(US20230295119, Compound 9S | US20230295119, Compou...)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619063(US20230295119, Compound 9I)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619064(US20230295119, Compound 9J)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619065(US20230295119, Compound 9K)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619067(US20230295119, Compound 9M)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619068(US20230295119, Compound 9N)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619069(US20230295119, Compound 9O)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619070(US20230295119, Compound 9P)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619071(US20230295119, Compound 9Q)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619062(US20230295119, Compound 9S | US20230295119, Compou...)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619074(US20230295119, Compound 9T)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619075(US20230295119, Compound 9U)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619076(US20230295119, Compound 9V)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619055(US20230295119, Compound 9W | US20230295119, Compou...)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619081(US20230295119, Compound 9AA)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619083(US20230295119, Compound 9CC)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619084(US20230295119, Compound 9DD)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619085(US20230295119, Compound 9EE)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619089(US20230295119, Compound 9II)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619090(US20230295119, Compound 9JJ)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619091(US20230295119, Compound 9KK)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619092(US20230295119, Compound 9LL)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619093(US20230295119, Compound 9MM)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619094(US20230295119, Compound 9NN)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619095(US20230295119, Compound 9OO)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619098(US20230295119, Compound 9RR)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619100(US20230295119, Compound 9SS)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619101(US20230295119, Compound 9TT)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619102(US20230295119, Compound 9UU)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619103(US20230295119, Compound 9VV)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619105(US20230295119, Compound 9XX)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619106(US20230295119, Compound 9YY)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619107(US20230295119, Compound 9ZZ)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

TargetNon-receptor tyrosine-protein kinase TYK2(Human)
Gossamer Bio Services

US Patent
LigandPNGBDBM619108(US20230295119, Compound 9AAA)
Affinity DataIC50: 5nMAssay Description:Compounds described herein were tested for the ability to inhibit activity of human JAK1, JAK2 and JAK3, which was achieved using TR-FRET assays. Bri...More data for this Ligand-Target Pair
In Depth
Date in BDB:
10/30/2023
Entry Details
Go to US Patent

Displayed 1 to 50 (of 1344 total ) | Next | Last >>
Jump to: